Scientists said Friday they have discovered a brand-new virus strain, which could change the way chronic and childhood kidney diseases are treated.
Researchers at the Centenary Institute in Australia noticed some immune-compromised laboratory mice were dying in middle-age, much earlier than their expected lifespan.
Further investigation revealed the mice were succumbing to kidney failure, according to the study published in the journal Cell.
Using leading-edge DNA sequencing technologies, the scientists, including those from the Memorial Sloan Kettering Cancer Center in the US, were able to pinpoint the cause as an entirely new parvovirus.
Parvoviruses are extremely small viruses that are generally benign, except in immune-compromised individuals.
The researchers are currently looking at ways they can translate these findings into clinical practice to improve outcomes for patients with chronic kidney disease.
"This virus is very widespread and has been affecting laboratory mice for 40 years or more, and we have good reason to suspect that both wild and laboratory mice unwittingly harbour it in their colonies," said Ben Roediger from Centenary Institute.
The discovery of this new strain of parvovirus has several important implications for human health, researchers said.
"This breakthrough provides new insight into virally-driven kidney disease, which is a major problem in kidney transplant patients," Roediger said.
"The virus itself appears to be highly specific to the kidney, which means we can potentially exploit its surface ("capsid") protein to develop gene therapies for inherited childhood kidney disease," he said.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
